Skip to main content
Equibles

MORGAN STANLEY

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 895421 NEW YORK, NY
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,835,088
-$707,793 QoQ
Shares Held
229,100
-27.7% QoQ
Ownership
0.230%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 209 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 38% Shared 0% None 62%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. SPRY ranks #223 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in SPRY

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,835,088 229,100
2026-03-31 $2,542,881 316,673
2025-12-31 $6,435,036 552,364
2025-09-30 $7,039,159 700,414
2025-06-30 $6,694,096 383,616
2025-03-31 $5,566,824 442,514
2024-12-31 $4,563,958 432,603
2024-09-30 $9,260,017 638,622
2024-06-30 $1,138,686 133,806
2024-03-31 $1,001,075 97,953
2023-12-31 $591,359 107,913
2023-09-30 $318,321 84,213
2023-06-30 $406,547 60,679
2023-03-31 $648,432 99,606
2022-12-31 $760,992 89,214
2022-09-30 $296,178 56,095
2022-06-30 $1,007,452 237,607
2022-03-31 $1,354,673 385,947
2021-12-31 $9,263,457 1,390,910
2021-09-30 $6,374,233 638,701
2021-06-30 $408,489 13,224
2020-12-31 $109,594 2,365